We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.69B
AUM Growth
-$542M
Cap. Flow
-$781M
Cap. Flow %
-21.18%
Top 10 Hldgs %
56.86%
Holding
480
New
156
Increased
61
Reduced
86
Closed
113

Sector Composition

Rank Sector Weight
1 Healthcare 19.77%
2 Technology 14.28%
3 Consumer Staples 10.98%
4 Energy 9.87%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
276
PUT
Tesla
TSLA
$1.4T
$289K 0.01%
12,500
IWM icon
277
CALL
iShares Russell 2000 ETF
IWM
$81.2B
$288K 0.01%
+105,000
New +$21.1M
AAPL icon
278
CALL
Apple
AAPL
$4.67T
$279K 0.01%
+74,000
New +$14.9M
EVLVW
279
DELISTED
Evolv Technologies Warrant
EVLVW
$259K 0.01%
463,341
VSAT icon
280
PUT
Viasat
VSAT
$10.4B
$238K 0.01%
73,300
RARE icon
281
CALL
Ultragenyx Pharmaceutical
RARE
$1.51B
$238K 0.01%
+60,000
New +$2.16M
SABR icon
282
PUT
Sabre
SABR
$860M
$238K 0.01%
688,600
CLMT icon
283
PUT
Calumet Specialty Products
CLMT
$4.67B
$234K 0.01%
+175,000
New +$2.23M
XIFR
284
PUT
XPLR Infrastructure LP
XIFR
$1.14B
$194K 0.01%
20,600
FSLR icon
285
CALL
First Solar
FSLR
$22B
$189K 0.01%
+15,000
New +$2.21M
HYG icon
286
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$173K ﹤0.01%
+500,000
New +$39.4M
CAPR icon
287
Capricor Therapeutics
CAPR
$547M
$169K ﹤0.01%
+17,054
New +$180K
VTYX
288
DELISTED
Ventyx Biosciences
VTYX
$169K ﹤0.01%
+79,000
New +$128K
UAL icon
289
PUT
United Airlines
UAL
$36.2B
$165K ﹤0.01%
+87,500
New +$6.45M
LVS icon
290
PUT
Las Vegas Sands
LVS
$28.7B
$164K ﹤0.01%
37,200
GLD icon
291
CALL
SPDR Gold Trust
GLD
$149B
$154K ﹤0.01%
+31,500
New +$9.54M
OCUL icon
292
CALL
Ocular Therapeutix
OCUL
$2.34B
$153K ﹤0.01%
120,000
XFOR icon
293
X4 Pharmaceuticals
XFOR
$401M
$152K ﹤0.01%
80,000
+71,580
+850% +$293K
XBI icon
294
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$149K ﹤0.01%
105,000
-95,000
-48% -$7.58M
NCLH icon
295
PUT
Norwegian Cruise Line
NCLH
$7.15B
$142K ﹤0.01%
188,800
RIG icon
296
CALL
Transocean
RIG
$6.53B
$140K ﹤0.01%
+400,000
New +$1.03M
INSM icon
297
PUT
Insmed
INSM
$27.6B
$138K ﹤0.01%
+27,000
New +$2.06M
LYV icon
298
PUT
Live Nation Entertainment
LYV
$40.4B
$137K ﹤0.01%
32,500
MPT
299
PUT
Medical Properties Trust
MPT
$2.39B
$131K ﹤0.01%
396,500
OCFT
300
DELISTED
OneConnect Financial Technology
OCFT
$130K ﹤0.01%
18,106
-65,151
-78% -$434K

Similar funds

UBS O'Connor's Q2 2025 Portfolio in Review

As of Q2 2025, UBS O'Connor held 480 positions worth $3.69B, down 13% from $4.23B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor withdrew a net $781M in Q2 2025, closing 113 positions and reducing 86 holdings. Its most notable exit was Discover Financial Services, an estimated $408M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Skechers worth $227M.

  • UBS O'Connor's largest Q2 2025 buy was Skechers: 3,598,177 shares worth $227M.
  • UBS O'Connor added most to Blueprint Medicines in Q2 2025, an estimated $176M increase.
  • UBS O'Connor's biggest Q2 2025 reduction was Hess, cutting an estimated $251M.
  • UBS O'Connor fully exited Discover Financial Services in Q2 2025, selling an estimated $408M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.69B portfolio in Q2 2025.
  • UBS O'Connor opened 156 new positions and closed 113 in Q2 2025.
  • UBS O'Connor's portfolio value fell 13% quarter-over-quarter to $3.69B.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.